The global Non-Opioid Pain Treatment market was valued at US$ 19550 million in 2023 and is anticipated to reach US$ 56280 million by 2030, witnessing a CAGR of 16.0% during the forecast period 2024-2030.

Non-Opioid Pain Treatment Market

Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Opioid Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Opioid Pain Treatment.

Report Scope

The Non-Opioid Pain Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-Opioid Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Opioid Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Opioid Pain Treatment Market Report

Report Metric	Details
Report Name	Non-Opioid Pain Treatment Market
Accounted market size in 2023	US$ 19550 million
Forecasted market size in 2030	US$ 56280 million
CAGR	16.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Medical Cannabis Treatment Capsaicin-derived Treatment Menthol-containing Treatment Omega 3 fatty acid-containing Treatment Botulinum Toxins
Segment by Application	Orthopaedic and Musculoskeletal Pain Neuropathic Pain Cancer Pain Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan PLC, Canopy Growth, Medical Marijuana Inc., Panag Pharma Inc., Tilray, Aphria Inc., Bedrocan, Cara Therapeutics, Centrexion Therapeutics, CHT Medical, Cronos Group, GW Pharmaceuticals, Medropharm Gmbh, US Worldmeds LLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Opioid Pain Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Opioid Pain Treatment Market growing?

Ans: The Non-Opioid Pain Treatment Market witnessing a CAGR of 16.0% during the forecast period 2024-2030.

What is the Non-Opioid Pain Treatment Market size in 2030?

Ans: The Non-Opioid Pain Treatment Market size in 2030 will be US$ 56280 million.

Who are the main players in the Non-Opioid Pain Treatment Market report?

Ans: The main players in the Non-Opioid Pain Treatment Market are Allergan PLC, Canopy Growth, Medical Marijuana Inc., Panag Pharma Inc., Tilray, Aphria Inc., Bedrocan, Cara Therapeutics, Centrexion Therapeutics, CHT Medical, Cronos Group, GW Pharmaceuticals, Medropharm Gmbh, US Worldmeds LLC

What are the Application segmentation covered in the Non-Opioid Pain Treatment Market report?

Ans: The Applications covered in the Non-Opioid Pain Treatment Market report are Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others

What are the Type segmentation covered in the Non-Opioid Pain Treatment Market report?

Ans: The Types covered in the Non-Opioid Pain Treatment Market report are Medical Cannabis Treatment, Capsaicin-derived Treatment, Menthol-containing Treatment, Omega 3 fatty acid-containing Treatment, Botulinum Toxins

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Medical Cannabis Treatment

1.2.3 Capsaicin-derived Treatment

1.2.4 Menthol-containing Treatment

1.2.5 Omega 3 fatty acid-containing Treatment

1.2.6 Botulinum Toxins

1.3 Market by Application

1.3.1 Global Non-Opioid Pain Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Orthopaedic and Musculoskeletal Pain

1.3.3 Neuropathic Pain

1.3.4 Cancer Pain

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Opioid Pain Treatment Market Perspective (2019-2030)

2.2 Non-Opioid Pain Treatment Growth Trends by Region

2.2.1 Global Non-Opioid Pain Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Opioid Pain Treatment Historic Market Size by Region (2019-2024)

2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Region (2025-2030)

2.3 Non-Opioid Pain Treatment Market Dynamics

2.3.1 Non-Opioid Pain Treatment Industry Trends

2.3.2 Non-Opioid Pain Treatment Market Drivers

2.3.3 Non-Opioid Pain Treatment Market Challenges

2.3.4 Non-Opioid Pain Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Opioid Pain Treatment Players by Revenue

3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2019-2024)

3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue

3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio

3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2023

3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served

3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service

3.7 Date of Enter into Non-Opioid Pain Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Opioid Pain Treatment Breakdown Data by Type

4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2019-2024)

4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2025-2030)

5 Non-Opioid Pain Treatment Breakdown Data by Application

5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2019-2024)

5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Opioid Pain Treatment Market Size (2019-2030)

6.2 North America Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Non-Opioid Pain Treatment Market Size by Country (2019-2024)

6.4 North America Non-Opioid Pain Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Opioid Pain Treatment Market Size (2019-2030)

7.2 Europe Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Non-Opioid Pain Treatment Market Size by Country (2019-2024)

7.4 Europe Non-Opioid Pain Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2019-2030)

8.2 Asia-Pacific Non-Opioid Pain Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Opioid Pain Treatment Market Size (2019-2030)

9.2 Latin America Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Non-Opioid Pain Treatment Market Size by Country (2019-2024)

9.4 Latin America Non-Opioid Pain Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2019-2030)

10.2 Middle East & Africa Non-Opioid Pain Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Allergan PLC

11.1.1 Allergan PLC Company Detail

11.1.2 Allergan PLC Business Overview

11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction

11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.1.5 Allergan PLC Recent Development

11.2 Canopy Growth

11.2.1 Canopy Growth Company Detail

11.2.2 Canopy Growth Business Overview

11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction

11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.2.5 Canopy Growth Recent Development

11.3 Medical Marijuana Inc.

11.3.1 Medical Marijuana Inc. Company Detail

11.3.2 Medical Marijuana Inc. Business Overview

11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction

11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.3.5 Medical Marijuana Inc. Recent Development

11.4 Panag Pharma Inc.

11.4.1 Panag Pharma Inc. Company Detail

11.4.2 Panag Pharma Inc. Business Overview

11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction

11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.4.5 Panag Pharma Inc. Recent Development

11.5 Tilray

11.5.1 Tilray Company Detail

11.5.2 Tilray Business Overview

11.5.3 Tilray Non-Opioid Pain Treatment Introduction

11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.5.5 Tilray Recent Development

11.6 Aphria Inc.

11.6.1 Aphria Inc. Company Detail

11.6.2 Aphria Inc. Business Overview

11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction

11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.6.5 Aphria Inc. Recent Development

11.7 Bedrocan

11.7.1 Bedrocan Company Detail

11.7.2 Bedrocan Business Overview

11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction

11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.7.5 Bedrocan Recent Development

11.8 Cara Therapeutics

11.8.1 Cara Therapeutics Company Detail

11.8.2 Cara Therapeutics Business Overview

11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction

11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.8.5 Cara Therapeutics Recent Development

11.9 Centrexion Therapeutics

11.9.1 Centrexion Therapeutics Company Detail

11.9.2 Centrexion Therapeutics Business Overview

11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction

11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.9.5 Centrexion Therapeutics Recent Development

11.10 CHT Medical

11.10.1 CHT Medical Company Detail

11.10.2 CHT Medical Business Overview

11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction

11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.10.5 CHT Medical Recent Development

11.11 Cronos Group

11.11.1 Cronos Group Company Detail

11.11.2 Cronos Group Business Overview

11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction

11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.11.5 Cronos Group Recent Development

11.12 GW Pharmaceuticals

11.12.1 GW Pharmaceuticals Company Detail

11.12.2 GW Pharmaceuticals Business Overview

11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction

11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.12.5 GW Pharmaceuticals Recent Development

11.13 Medropharm Gmbh

11.13.1 Medropharm Gmbh Company Detail

11.13.2 Medropharm Gmbh Business Overview

11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction

11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.13.5 Medropharm Gmbh Recent Development

11.14 US Worldmeds LLC

11.14.1 US Worldmeds LLC Company Detail

11.14.2 US Worldmeds LLC Business Overview

11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction

11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2019-2024)

11.14.5 US Worldmeds LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Allergan plc

Canopy Growth

Medical Marijuana Inc.

Centrexion Therapeutics

List of Tables

Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Medical Cannabis Treatment

Table 3. Key Players of Capsaicin-derived Treatment

Table 4. Key Players of Menthol-containing Treatment

Table 5. Key Players of Omega 3 fatty acid-containing Treatment

Table 6. Key Players of Botulinum Toxins

Table 7. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Non-Opioid Pain Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Non-Opioid Pain Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Non-Opioid Pain Treatment Market Share by Region (2019-2024)

Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Non-Opioid Pain Treatment Market Share by Region (2025-2030)

Table 13. Non-Opioid Pain Treatment Market Trends

Table 14. Non-Opioid Pain Treatment Market Drivers

Table 15. Non-Opioid Pain Treatment Market Challenges

Table 16. Non-Opioid Pain Treatment Market Restraints

Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Non-Opioid Pain Treatment Market Share by Players (2019-2024)

Table 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2023)

Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service

Table 24. Date of Enter into Non-Opioid Pain Treatment Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Non-Opioid Pain Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Non-Opioid Pain Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Non-Opioid Pain Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Non-Opioid Pain Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Non-Opioid Pain Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Non-Opioid Pain Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Non-Opioid Pain Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Non-Opioid Pain Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. Allergan PLC Company Detail

Table 50. Allergan PLC Business Overview

Table 51. Allergan PLC Non-Opioid Pain Treatment Product

Table 52. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 53. Allergan PLC Recent Development

Table 54. Canopy Growth Company Detail

Table 55. Canopy Growth Business Overview

Table 56. Canopy Growth Non-Opioid Pain Treatment Product

Table 57. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 58. Canopy Growth Recent Development

Table 59. Medical Marijuana Inc. Company Detail

Table 60. Medical Marijuana Inc. Business Overview

Table 61. Medical Marijuana Inc. Non-Opioid Pain Treatment Product

Table 62. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 63. Medical Marijuana Inc. Recent Development

Table 64. Panag Pharma Inc. Company Detail

Table 65. Panag Pharma Inc. Business Overview

Table 66. Panag Pharma Inc. Non-Opioid Pain Treatment Product

Table 67. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 68. Panag Pharma Inc. Recent Development

Table 69. Tilray Company Detail

Table 70. Tilray Business Overview

Table 71. Tilray Non-Opioid Pain Treatment Product

Table 72. Tilray Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 73. Tilray Recent Development

Table 74. Aphria Inc. Company Detail

Table 75. Aphria Inc. Business Overview

Table 76. Aphria Inc. Non-Opioid Pain Treatment Product

Table 77. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 78. Aphria Inc. Recent Development

Table 79. Bedrocan Company Detail

Table 80. Bedrocan Business Overview

Table 81. Bedrocan Non-Opioid Pain Treatment Product

Table 82. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 83. Bedrocan Recent Development

Table 84. Cara Therapeutics Company Detail

Table 85. Cara Therapeutics Business Overview

Table 86. Cara Therapeutics Non-Opioid Pain Treatment Product

Table 87. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 88. Cara Therapeutics Recent Development

Table 89. Centrexion Therapeutics Company Detail

Table 90. Centrexion Therapeutics Business Overview

Table 91. Centrexion Therapeutics Non-Opioid Pain Treatment Product

Table 92. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 93. Centrexion Therapeutics Recent Development

Table 94. CHT Medical Company Detail

Table 95. CHT Medical Business Overview

Table 96. CHT Medical Non-Opioid Pain Treatment Product

Table 97. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 98. CHT Medical Recent Development

Table 99. Cronos Group Company Detail

Table 100. Cronos Group Business Overview

Table 101. Cronos Group Non-Opioid Pain Treatment Product

Table 102. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 103. Cronos Group Recent Development

Table 104. GW Pharmaceuticals Company Detail

Table 105. GW Pharmaceuticals Business Overview

Table 106. GW Pharmaceuticals Non-Opioid Pain Treatment Product

Table 107. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 108. GW Pharmaceuticals Recent Development

Table 109. Medropharm Gmbh Company Detail

Table 110. Medropharm Gmbh Business Overview

Table 111. Medropharm Gmbh Non-Opioid Pain Treatment Product

Table 112. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 113. Medropharm Gmbh Recent Development

Table 114. US Worldmeds LLC Company Detail

Table 115. US Worldmeds LLC Business Overview

Table 116. US Worldmeds LLC Non-Opioid Pain Treatment Product

Table 117. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2019-2024) & (US$ Million)

Table 118. US Worldmeds LLC Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-Opioid Pain Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Non-Opioid Pain Treatment Market Share by Type: 2023 VS 2030

Figure 3. Medical Cannabis Treatment Features

Figure 4. Capsaicin-derived Treatment Features

Figure 5. Menthol-containing Treatment Features

Figure 6. Omega 3 fatty acid-containing Treatment Features

Figure 7. Botulinum Toxins Features

Figure 8. Global Non-Opioid Pain Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Non-Opioid Pain Treatment Market Share by Application: 2023 VS 2030

Figure 10. Orthopaedic and Musculoskeletal Pain Case Studies

Figure 11. Neuropathic Pain Case Studies

Figure 12. Cancer Pain Case Studies

Figure 13. Others Case Studies

Figure 14. Non-Opioid Pain Treatment Report Years Considered

Figure 15. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Non-Opioid Pain Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Non-Opioid Pain Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Non-Opioid Pain Treatment Market Share by Players in 2023

Figure 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2023

Figure 21. North America Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Non-Opioid Pain Treatment Market Share by Country (2019-2030)

Figure 23. United States Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Non-Opioid Pain Treatment Market Share by Country (2019-2030)

Figure 27. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Non-Opioid Pain Treatment Market Share by Region (2019-2030)

Figure 35. China Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Non-Opioid Pain Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Non-Opioid Pain Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 50. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 51. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 52. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 53. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 54. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 55. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 56. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 57. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 58. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 59. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 60. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 61. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 62. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Internal Neuromodulation Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24F2529

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Acetaminophen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-26Z11859

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Global Muscle Pain Relief Patches Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6F17019

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

Global Muscle & Joint Pain Relief Patches Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-0S17129

Thu Mar 21 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions